Please provide your email address to receive an email when new articles are posted on . Transcatheter tricuspid valve replacement in patients with trans-tricuspid valve pacemaker leads without ...

SAN FRANCISCO, CA—Patients with severe tricuspid regurgitation (TR) treated with transcatheter valve replacement experienced a significant improvement in TR grade and had “meaningful” improvements in ...

Please provide your email address to receive an email when new articles are posted on . Transcatheter tricuspid valve replacement plus medical therapy improved outcomes vs. medical therapy alone in ...

The investigational transfemoral EVOQUE tricuspid valve replacement system (Edwards Lifesciences) significantly reduced severity of tricuspid regurgitation and improved quality of life at 30 days in ...

IRVINE, Calif., Aug. 17, 2022 /PRNewswire/ -- Edwards Lifesciences Corporation (NYSE: EW), today announced the company's PASCAL Precision transcatheter valve repair system received CE Mark for the ...

DUBLIN--(BUSINESS WIRE)--The "Tricuspid Valve Repair Market Size, Share & Trends Analysis Report By End-use (Ambulatory Surgical Centers, Hospitals), By Indication (Tricuspid Valve Regurgitation, ...

Abbott has begun its first randomized, pivotal trial to test a new method of fixing leaky tricuspid heart valves, where there are currently no approved minimally invasive repair therapies available.

Edwards Lifesciences has received US Food and Drug Administration (FDA) approval for its Evoque tricuspid valve replacement system, which becomes the first transcatheter therapy to be approved in the ...

While minimally invasive repair devices have shown progress in stemming leaks of the heart’s notoriously tricky tricuspid valve, Edwards Lifesciences aims to show that replacing the valve entirely ...

TRiCaresAnnouncesSuccessfulImplantationofMinimallyInvasiveTopazTricuspidHeartValveReplacementSystemin Patient with a Pacemaker Paris, France and Munich, Germany ...

(RTTNews) - Abbott (ABT) said that its TriClip Transcatheter Tricuspid Valve Repair System has received CE Mark and is now approved for use in Europe and other countries that recognize CE Mark as a ...

Patients with moderate tricuspid regurgitation (TR) undergoing surgery for mitral valve disease have a significant improvement in TR grade, according to the results of a new study. In early ...